Amgen ROCE Ratio 2011-2026 | AMGN

Annual ROCE Ratio Amgen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
104.87	123.5	126.72	261.29	114.01	97.13	20.64	19.39	14.06	14.75	13.46	9.99	10.08	12.1	12.08

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
261.29	9.99	63.6

Quarterly ROCE Ratio Amgen

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
444.96	618.67	647.61	330.81	340.85	61.79	87.86	84.99	99.64	75.79	101.39	100.91	103.91	78.84	97.42	90.41	85.38	63.05	72.71	63.79	51.82	30.62	39.08	37.87	35.15	24.47	32.79	32.66	32.09	22.92	28.61	25.97	25.95	18.36	26.0	27.95	27.58	21.18	28.65	28.47	29.79	23.55	26.31	21.6	20.27	16.55	2.76	7.0	6.79

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
647.61	2.76	89.87

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Evogene Ltd. EVGN	-39.87	$ 0.75	-4.66 %	$ 27.9 M	Israel
ACADIA Pharmaceuticals ACAD	31.5	$ 22.2	-2.07 %	$ 3.68 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Galapagos NV GLPG	-3.51	$ 27.86	-1.97 %	$ 2.69 B	Belgium
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Innate Pharma S.A. IPHA	0.41	$ 1.49	6.43 %	$ 235 M	France
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	-4.81	$ 101.57	-0.48 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	163.63	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Allakos ALLK	-116.14	-	-	$ 28.6 M	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	-146.69	$ 2.98	2.41 %	$ 4.91 M	Israel
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Applied Therapeutics APLT	394.73	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	211.07	$ 4.05	-0.98 %	$ 433 M	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	123.77	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	-6.45	$ 22.37	-3.95 %	$ 2.85 B	USA
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Nanobiotix S.A. NBTX	-31.68	$ 32.99	-0.39 %	$ 286 B	France
Athira Pharma ATHA	-368.0	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	-168.29	-	-52.27 %	$ 4.45 M	USA
Aileron Therapeutics ALRN	-299.27	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	-151.88	$ 1.41	-4.73 %	$ 375 M	Britain
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain
Atreca BCEL	-34.9	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	19.77	-	-4.8 %	$ 255 M	USA
Pharming Group N.V. PHAR	281.39	$ 16.36	-0.4 %	$ 7.59 B	Niderland
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands